Position in ELAN
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$287,686
+$119,908 QoQ
Shares Held
12,022
+62.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Kestra Advisory Services, LLC holds $8,161,285 across 14 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
23,140 | $2,735,379 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
47,388 | $1,427,326 | |
| 3 | VTRS |
Viatris Inc
|
90,526 | $1,223,006 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,288 | $763,758 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
21,704 | $450,575 | |
| 6 | HLN |
Haleon plc
|
42,584 | $426,265 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
12,022 | $287,686 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
3,329 | $252,504 |
All Filings in ELAN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $287,686 | 12,022 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $167,778 | 7,414 | Shares | Sole | 2026-02-13 | |
| 2024-03-31 | $1,557,247 | 95,654 | Shares | Sole | 2024-05-15 | |
| 2022-06-30 | $241,174 | 12,286 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $290,094 | 11,119 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $348,818 | 12,291 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $390,716 | 12,252 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $423,877 | 12,219 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $335,111 | 11,379 | Shares | Sole | 2022-07-27 | |
| No filing history on record for this holder in this stock. | ||||||